Tempest Therapeutics, Inc. Lessee, Operating Lease, Liability, Undiscounted Excess Amount
Tempest Therapeutics, Inc. (TPST) had Lessee, Operating Lease, Liability, Undiscounted Excess Amount of $5.16 million as of 2022-12-31, per its 10-K filed 2023-03-22.
Discontinued › Notes › Leases
us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount · last filed 2023-03-22
- 2022-12-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $5.16M.
- 2022-03-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $178.00K.
- 2021-12-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $225.00K.
- 2021-09-30: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $278.00K.
| Period end | Lessee, Operating Lease, Liability, Undiscounted Excess Amount |
|---|---|
| 2022-12-31 | $5.16M 10-K · filed 2023-03-22 |
| 2022-03-31 | $178.00K 10-Q · filed 2022-05-13 |
| 2021-12-31 | $225.00K 10-K · filed 2022-03-29 |
| 2021-09-30 | $278.00K 10-Q · filed 2021-11-10 |
| 2021-06-30 | $321.00K 10-Q · filed 2021-08-12 |
| 2021-03-31 | $240.00K 10-Q · filed 2021-05-13 |
| 2020-12-31 | $279.00K 10-K · filed 2021-03-29 |
| 2020-09-30 | $320.00K 10-Q · filed 2020-11-09 |
| 2020-06-30 | $369.00K 10-Q · filed 2020-08-10 |
| 2020-03-31 | $424.00K 10-Q · filed 2020-05-08 |
| 2019-12-31 | $533.00K 10-K · filed 2020-03-11 |
| 2019-09-30 | $604.00K 10-Q · filed 2019-11-13 |
| 2019-06-30 | $400.00K 10-Q · filed 2019-08-12 |
| 2019-03-31 | $146.00K 10-Q · filed 2019-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B |